The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Clostridium difficile— More Difficult Than Ever
Abstract
Because of mutations in this opportunistic pathogen, infections with C. difficile have become both more prevalent and more virulent. This article summarizes recent changes in the epidemiology of this infection and explains what is known about the changes in disease severity and the response to therapy. The authors discuss the use of new antibiotics, probiotics, immunotherapy, and even bacteriotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S., Bourgault, A.-M., Nguyen, T., Frenette, C., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,946
Warny, M., Pepin, J., Fang, A., Killgore, G., Thompson, A., Brazier, J., Frost, E., & McDonald, L. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67420-x · Cited by 1,430
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Pepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Self-citationMcFarland, L. V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00465.x · Cited by 872
McFarland, L. V. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510480037031 · Cited by 857
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
Self-citationClostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
McDonald, L. C., Owings, M., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.051064 · Cited by 788
HALL, I. C. (1935) · American Journal of Diseases of Children · doi:10.1001/archpedi.1935.01970020105010 · Cited by 772
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis
D'Souza, A. L., Rajkumar, C., Cooke, J., & Bulpitt, C. J. (2002) · BMJ · doi:10.1136/bmj.324.7350.1361 · Cited by 664
Muto, C. A., Pokrywka, M., Shutt, K., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T., Croyle, K., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502539 · Cited by 619
Clindamycin-Associated Colitis: A Prospective Study
TEDESCO, F. J., BARTON, R. W., & ALPERS, D. H. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-429 · Cited by 606
Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
Pepin, J., Alary, M.-E., Valiquette, L., Raiche, E., Ruel, J., Fulop, K., Godin, D., & Bourassa, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430315 · Cited by 570
Aas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole
Musher, D. M., Aslam, S., Logan, N., Nallacheru, S., Bhaila, I., Borchert, F., & Hamill, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/430311 · Cited by 504
Barth, H., Aktories, K., Popoff, M. R., & Stiles, B. G. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.373-402.2004 · Cited by 399
Clostridium difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30141083 · Cited by 398
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
Aslam, S., Hamill, R. J., & Musher, D. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70215-2 · Cited by 366
Johnson, S., Schriever, C., Galang, M., Kelly, C. P., & Gerding, D. N. (2007) · Clinical Infectious Diseases · doi:10.1086/511870 · Cited by 312
Self-citationLeung, D. Y. M., Kelly, C. P., Boguniewicz, M., Pothoulakis, C., LaMont, J. T., & Flores, A. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83393-1 · Cited by 278
Self-citationIntravenous immunoglobulin therapy for severe Clostridium difficile colitis
Salcedo, J., Keates, S., Pothoulakis, C., Warny, M., Castagliuolo, I., LaMont, J. T., & Kelly, C. P. (1997) · Gut · doi:10.1136/gut.41.3.366 · Cited by 264
Self-citationClostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea
Sougioultzis, S., Kyne, L., Drudy, D., Keates, S., Maroo, S., Pothoulakis, C., Giannasca, P. J., Lee, C. K., Warny, M., Monath, T. P., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.004 · Cited by 260
Self-citationAutocatalytic cleavage of Clostridium difficile toxin B
Reineke, J., Tenzer, S., Rupnik, M., Koschinski, A., Hasselmayer, O., Schrattenholz, A., Schild, H., & von Eichel-Streiber, C. (2007) · Nature · doi:10.1038/nature05622 · Cited by 244
Decrease in Nosocomial Clostridium difficile–Associated Diarrhea by Restricting Clindamycin Use
Pear, S. M., Williamson, T. H., Bettin, K. M., Gerding, D. N., & Galgiani, J. N. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-4-199402150-00003 · Cited by 235
Barbut, F. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45804-0 · Cited by 211
Louie, T. J., Peppe, J., Watt, C. K., Johnson, D., Mohammed, R., Dow, G., Weiss, K., Simon, S., John, J. F., Garber, G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/506349 · Cited by 203
McPherson, S., Rees, C. J., Ellis, R., Soo, S., & Panter, S. J. (2006) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0511-8 · Cited by 201
Wilcox, M. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh176 · Cited by 200
Geric, B., Carman, R. J., Rupnik, M., Genheimer, C. W., Sambol, S. P., Lyerly, D. M., Gerding, D. N., & Johnson, S. (2006) · The Journal of Infectious Diseases · doi:10.1086/501368 · Cited by 196
Recurrence of symptoms in Clostridium difficile infection—relapse or reinfection?
Wilcox, M. H., Fawley, W. N., Settle, C. D., & Davidson, A. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90062-7 · Cited by 175
McFarland, L. V. (1994) · JAMA · doi:10.1001/jama.271.24.1913 · Cited by 166
Colonization for the Prevention of Clostridium difficile Disease in Hamsters
Sambol, S. P., Merrigan, M. M., Tang, J. K., Johnson, S., & Gerding, D. N. (2002) · The Journal of Infectious Diseases · doi:10.1086/345676 · Cited by 164
Apisarnthanarak, A., Razavi, B., & Mundy, L. M. (2002) · Clinical Infectious Diseases · doi:10.1086/342334 · Cited by 161
Kotloff, K. L., Wasserman, S. S., Losonsky, G. A., Thomas, W. D., Nichols, R., Edelman, R., Bridwell, M. W., & Monath, T. P. C. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.988-995.2001 · Cited by 156
Treatment of relapsingClostridium difficile diarrhoea by administration of a non-toxigenic strain
SEAL, D. V., Borriello, S. P., Barclay, F. E., Welch, A. R., Piper, M., & Bonnycastle, M. (1987) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02097191 · Cited by 155
Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea
Juang, P., Skledar, S. J., Zgheib, N. K., Paterson, D. L., Vergis, E. N., Shannon, W. D., Ansani, N. T., & Branch, R. A. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.06.007 · Cited by 154
Wilcox, M. H., & Howe, R. A. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.4.673 · Cited by 122
Kelly, C. P., Pothoulakis, C., Orellana, J., & LaMont, J. T. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91781-x · Cited by 118
Self-citationSegarra‐Newnham, M. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k110 · Cited by 83
An epidemic of pseudomembranous colitis: importance of person to person spread.
Nolan, N. P., Kelly, C. P., Humphreys, J. F., Cooney, C., O'Connor, R., Walsh, T. N., Weir, D. G., & O’Briain, D. S. (1987) · Gut · doi:10.1136/gut.28.11.1467 · Cited by 70
Self-citationEmerging Therapies in the Treatment of Clostridium difficile–Associated Disease
Jodlowski, T. Z., Oehler, R. L., Kam, L. W., & Melnychuk, I. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h340 · Cited by 31
Pathogenicity ofClostridium difficileToxins
Warny, M., & Kelly, C. P. (2014) · ASM Press eBooks · doi:10.1128/9781555817848.ch27 · Cited by 15
Self-citationThe Second International Conference on Women and Infectious Diseases
McDonald, M., & Romero‐Steiner, S. (2006) · Emerging infectious diseases · doi:10.3201/eid1211.061025 · Cited by 12
Cited by
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Louie, T. J., Miller, M. A., Mullane, K. M., Weiss, K., Lentnek, A., Golan, Y., Gorbach, S., Sears, P., & Shue, Y.-K. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910812 · Cited by 1,585
The Application of Ecological Theory Toward an Understanding of the Human Microbiome
Costello, E. K., Stagaman, K., Dethlefsen, L., Bohannan, B. J. M., & Relman, D. A. (2012) · Science · doi:10.1126/science.1224203 · Cited by 1,437
Treating Clostridium difficile infection with fecal microbiota transplantation
Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., Kelly, C., Khoruts, A., Louie, T., Martinelli, L. P., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.014 · Cited by 1,003
Self-citation
Metadata
- Authors
- Kelly, C. P., & LaMont, J. T.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-30
- Volume
- 359
- Issue
- 18
- Pages
- 1932-1940
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2065777365
- Cited by
- 1,313
- References
- 47
- FWCI
- 44.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.